135 related articles for article (PubMed ID: 2079426)
1. The effect of focal cerebral atrophy in positron emission tomographic studies of aging and dementia.
Chawluk JB; Dann R; Alavi A; Hurtig HI; Gur RE; Resnick S; Zimmerman RA; Reivich M
Int J Rad Appl Instrum B; 1990; 17(8):797-804. PubMed ID: 2079426
[TBL] [Abstract][Full Text] [Related]
2. Correction of positron emission tomography data for cerebral atrophy.
Herscovitch P; Auchus AP; Gado M; Chi D; Raichle ME
J Cereb Blood Flow Metab; 1986 Feb; 6(1):120-4. PubMed ID: 3484745
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography in aging and dementia: effect of cerebral atrophy.
Chawluk JB; Alavi A; Dann R; Hurtig HI; Bais S; Kushner MJ; Zimmerman RA; Reivich M
J Nucl Med; 1987 Apr; 28(4):431-7. PubMed ID: 3494824
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomographic (PET) studies in dementia.
Goto I; Taniwaki T; Hosokawa S; Otsuka M; Ichiya Y; Ichimiya A
J Neurol Sci; 1993 Jan; 114(1):1-6. PubMed ID: 8433091
[TBL] [Abstract][Full Text] [Related]
5. Assessment of demented patients by dynamic SPECT of inhaled xenon-133.
Komatani A; Yamaguchi K; Sugai Y; Takanashi T; Kera M; Shinohara M; Kawakatsu S
J Nucl Med; 1988 Oct; 29(10):1621-6. PubMed ID: 3262723
[TBL] [Abstract][Full Text] [Related]
6. Imaging dementia with SPECT.
Holman BL; Nagel JS; Johnson KA; Hill TC
Ann N Y Acad Sci; 1991; 620():165-74. PubMed ID: 2035940
[No Abstract] [Full Text] [Related]
7. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
8. PET studies in dementia.
Herholz K
Ann Nucl Med; 2003 Apr; 17(2):79-89. PubMed ID: 12790355
[TBL] [Abstract][Full Text] [Related]
9. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia.
Tanna NK; Kohn MI; Horwich DN; Jolles PR; Zimmerman RA; Alves WM; Alavi A
Radiology; 1991 Jan; 178(1):123-30. PubMed ID: 1984290
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging.
Fazekas F; Alavi A; Chawluk JB; Zimmerman RA; Hackney D; Bilaniuk L; Rosen M; Alves WM; Hurtig HI; Jamieson DG
J Nucl Med; 1989 Oct; 30(10):1607-15. PubMed ID: 2795200
[TBL] [Abstract][Full Text] [Related]
12. Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia.
Meguro K; Doi C; Ueda M; Yamaguchi T; Matsui H; Kinomura S; Itoh M; Yamada K; Sasaki H
Neuroradiology; 1991; 33(4):305-9. PubMed ID: 1922743
[TBL] [Abstract][Full Text] [Related]
13. Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients.
Kawamura J; Meyer JS; Ichijo M; Kobari M; Terayama Y; Weathers S
J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):182-7. PubMed ID: 8437007
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in Alzheimer's disease.
Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
[TBL] [Abstract][Full Text] [Related]
15. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
16. Aging, dementia, and brain atrophy: a longitudinal computed tomographic study.
Gado M; Hughes CP; Danziger W; Chi D
AJNR Am J Neuroradiol; 1983; 4(3):699-702. PubMed ID: 6410835
[TBL] [Abstract][Full Text] [Related]
17. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
Okada J; Peppard R; Calne DB
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
[TBL] [Abstract][Full Text] [Related]
18. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.
Ibáñez V; Pietrini P; Alexander GE; Furey ML; Teichberg D; Rajapakse JC; Rapoport SI; Schapiro MB; Horwitz B
Neurology; 1998 Jun; 50(6):1585-93. PubMed ID: 9633698
[TBL] [Abstract][Full Text] [Related]
19. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
González RG; Fischman AJ; Guimaraes AR; Carr CA; Stern CE; Halpern EF; Growdon JH; Rosen BR
AJNR Am J Neuroradiol; 1995 Oct; 16(9):1763-70. PubMed ID: 8693972
[TBL] [Abstract][Full Text] [Related]
20. Relation of measured brain glucose utilisation and cerebral atrophy in man.
Schlageter NL; Horwitz B; Creasey H; Carson R; Duara R; Berg GW; Rapoport SI
J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):779-85. PubMed ID: 3497229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
